PMID: 2496196Jan 1, 1989Paper

A marked rise in 5-S-cysteinyl-dopamine levels in guinea-pig striatum following reserpine treatment

Journal of Neural Transmission
B Fornstedt, A Carlsson

Abstract

Reserpine administration (5 mg/kg, i.p.) to guinea pigs resulted in marked and long lasting dopamine (DA) depletion and a rapid, short lasting, increase of 3,4-dihydroxyphenylacetic acid (DOPAC) in the striatum. A marked and sustained increase of the level of 5-S-cysteinyl-dopamine, which is an adduct presumably formed following autoxidation of DA, started 3-4 h following the DA and DOPAC changes. Only small changes in the levels of the 5-S-cysteinyl adducts of DOPAC and 3,4-dihydroxyphenylalanine (DOPA) were found.

References

Jul 29, 1977·Science·M M WickE Frei
Feb 1, 1975·Archives of Neurology·L M AmbaniS Murphy
Oct 27, 1975·Biochemical and Biophysical Research Communications·M ScheulenH Remmer
Jan 1, 1985·Journal of Neural Transmission·E RosengrenA Carlsson
Oct 1, 1983·Mutation Research·P MoldéusB Lambert
Oct 1, 1984·Bulletin of Environmental Contamination and Toxicology·R A Laskowski-Hoke, B L Prater

❮ Previous
Next ❯

Citations

Apr 29, 1999·Journal of Neuroscience Research·A H StokesK E Vrana
Jan 1, 1991·Journal of Neural Transmission. General Section·P DostertE Frigerio
Jan 1, 1995·Journal of Neural Transmission. Parkinson's Disease and Dementia Section·D A LoefflerW R Matson
Jan 1, 1995·Journal of Neural Transmission. Parkinson's Disease and Dementia Section·E Lorenc-KociS Wolfarth
Jan 1, 1989·Journal of Neural Transmission. Parkinson's Disease and Dementia Section·B FornstedtA Carlsson
Mar 5, 2009·Molecular Neurobiology·Thomas S Guillot, Gary W Miller
Mar 5, 1996·Proceedings of the National Academy of Sciences of the United States of America·T G HastingsM J Zigmond
Jan 1, 1991·Acta Neurologica Scandinavica. Supplementum·A Carlsson, B Fornstedt
May 11, 1992·Annals of the New York Academy of Sciences·R W Fuller
Feb 8, 2002·Journal of Addictive Diseases·Arthur K Cho, William P Melega
Aug 26, 1998·Reviews in the Neurosciences·E BezardC E Gross
Feb 1, 1991·Journal of Neurochemistry·B Fornstedt, A Carlsson
Aug 1, 1990·Journal of Neurochemistry·B FornstedtA Carlsson
Aug 5, 2008·Biochimica Et Biophysica Acta·Angela De IuliisFabio Vianello
Jun 6, 2008·Neurotoxicology·Jaime M HatcherGary W Miller
Feb 13, 2007·Experimental Neurology·Jaime M HatcherGary W Miller
Nov 8, 2006·Movement Disorders : Official Journal of the Movement Disorder Society·Penelope J Hallett, J M Brotchie
Nov 11, 2008·Annals of the New York Academy of Sciences·Donald M KuhnDavid M Thomas
Oct 22, 2010·Trends in Neurosciences·Lara Lourenço VendaRichard Wade-Martins
Jul 1, 2006·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Jason R RichardsonGary W Miller
Dec 7, 2019·Journal of Neural Transmission·David S Goldstein
Mar 7, 1998·The Journal of Biological Chemistry·Y LuoG S Roth
Dec 6, 2017·International Journal of Molecular Medicine·Xiao-Liang LiuGuang-Ren Li
Jan 1, 1990·Acta Neurologica Scandinavica. Supplementum·B Fornstedt
Feb 1, 1997·Chemical Research in Toxicology·X M ShenG Dryhurst

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.